PT - JOURNAL ARTICLE AU - Garchitorena, Andres AU - Rasoloharimanana, Lova Tsikiniaina AU - Rakotonanahary, Rado JL AU - Evans, Michelle V AU - Miller, Ann C. AU - Finnegan, Karen E. AU - Cordier, Laura F. AU - Cowley, Giovanna AU - Razafinjato, Benedicte AU - Randriamanambintsoa, Marius AU - Andrianambinina, Samuel AU - Popper, Stephen AU - Hotahiene, Raphaël AU - Bonds, Matthew H. AU - Schoenhals, Matthieu TI - Morbidity and mortality burden of COVID-19 in rural Madagascar: results from a longitudinal cohort and nested seroprevalence study AID - 10.1101/2023.03.24.23287674 DP - 2023 Jan 01 TA - medRxiv PG - 2023.03.24.23287674 4099 - http://medrxiv.org/content/early/2023/03/24/2023.03.24.23287674.short 4100 - http://medrxiv.org/content/early/2023/03/24/2023.03.24.23287674.full AB - Introduction Three years into the pandemic, there remains significant uncertainty about the true infection and mortality burden of COVID-19 in the WHO-Africa region. High quality, population-representative studies in Africa are rare and tend to be conducted in national capitals or large cities, leaving a substantial gap in our understanding of the impact of COVID-19 in rural, low-resource settings. Here, we estimated the spatio-temporal morbidity and mortality burden associated with COVID-19 in a rural health district of Madagascar until the first half of 2021.Methods We integrated a nested seroprevalence study within a pre-existing longitudinal cohort conducted in a representative sample of 1600 households in Ifanadiana District, Madagascar. Socio-demographic and health information was collected in combination with dried blood spots for about 6500 individuals of all ages, which were analysed to detect IgG and IgM antibodies against four specific proteins of SARS-CoV2 in bead-based multiplex immunoassay. We evaluated spatio-temporal patterns in COVID-19 infection history and its associations with several geographic, socio-economic and demographic factors via logistic regressions.Results Eighteen percent of people had been infected by April-June 2021, with seroprevalence increasing with individuals’ age. COVID-19 primarily spread along the only paved road and in major towns during the first epidemic wave, subsequently spreading along secondary roads during the second wave to more remote areas. Wealthier individuals and those with occupations such as commerce and formal employment were at higher risk of being infected in the first wave. Adult mortality increased in 2020, particularly for older men for whom it nearly doubled up to nearly 40 deaths per 1000. Less than 10% of mortality in this period could be directly attributed to COVID-19 deaths given known infection fatality ratios and observed seroprevalence in the district.Conclusion Our study provides a very granular understanding on COVID-19 transmission and mortality in a rural population of sub-Saharan Africa and suggests that the disease burden in these areas may have been substantially underestimated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by internal funding from Pivot, by the Herrnstein Family Foundation, and by a grant from the Agence Nationale de la Recherche (Project ANR-19-CE36-0001-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Madagascar National Ethics committee (CERBM) and IRB of Harvard Medical School gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors